RESUMEN
BACKGROUND: The diagnosis of infective endocarditis (IE) is based on microbiological analyses and diagnostic imaging of cardiac manifestations. Echocardiography (ECHO) is preferred for visualization of IE-induced cardiac manifestations. We investigated associations between bacterial infections and IE manifestations diagnosed by ECHO. METHODS: In this cohort study, data from patients aged 18 years or above, with definite IE admitted at the Karolinska University Hospital between 2008 and 2017 were obtained from Swedish National Registry of Endocarditis. Bacteria registered as pathogen were primarily selected from positive blood culture and for patients with negative blood culture, bacteria found in culture or PCR from postoperative material was registered as pathogen. Patients with negative results from culture or PCR, and patients who did not undergo ECHO during hospital stay, were excluded. IE manifestations diagnosed by ECHO were obtained from the registry. Chi-squared test and two-sided Fisher's exact test was used for comparisons between categorical variables, and student's t test was used for continuous numerical variables. Multivariable analyses were performed using logistic regression. Secular trend analyses were performed using linear regression. Associations and the strength between the variables were estimated using odds ratios (ORs) with 95% confidence intervals (CIs). P < 0.05 was considered significant. RESULTS: The most common bacteria were Staphylococcus aureus (n = 239, 49%) and viridans group streptococci (n = 102, 21%). The most common manifestations were vegetation in the mitral (n = 195, 40%), aortic (n = 190, 39%), and tricuspid valves (n = 108, 22%). Associations were seen between aortic valve vegetations and Enterococcus faecalis among patients with native aortic valves, between mitral valve vegetations and streptococci of group B or viridans group, between tricuspid valve vegetations and S. aureus among patients with intravenous drug abuse, and between perivalvular abscesses as well as cardiovascular implantable electronic device (CIED)-associated IE and coagulase negative staphylococci (all P < 0.05). CONCLUSIONS: Associations were found between certain bacterial species and specific ECHO manifestations. Our study contributes to a better understanding of IE manifestations and their underlying bacterial etiology, which pathogens can cause severe infections and might require close follow-up and surgical treatment.
Asunto(s)
Endocarditis Bacteriana/microbiología , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/aislamiento & purificación , Infecciones Estreptocócicas/microbiología , Estreptococos Viridans/aislamiento & purificación , Absceso/microbiología , Adulto , Anciano , Válvula Aórtica/diagnóstico por imagen , Válvula Aórtica/microbiología , Ecocardiografía , Endocarditis Bacteriana/sangre , Endocarditis Bacteriana/diagnóstico por imagen , Endocarditis Bacteriana/cirugía , Femenino , Mortalidad Hospitalaria , Hospitales Universitarios , Humanos , Masculino , Persona de Mediana Edad , Válvula Mitral/diagnóstico por imagen , Válvula Mitral/microbiología , Sistema de Registros , Estudios Retrospectivos , Staphylococcus aureus/genética , Abuso de Sustancias por Vía Intravenosa/microbiología , Suecia , Resultado del Tratamiento , Estreptococos Viridans/genéticaRESUMEN
Pharmaceutical residues and other emerging substances commonly summarised as micropollutants pass through wastewater treatment plants (WWTPs) and end up in the receiving waters and sludge. Many studies have investigated the removal efficiency of various techniques but a holistic evaluation of various relevant treatment alternatives regarding both the removal efficiency for various micropollutants, investment and operating costs, environmental impacts and future comprehensiveness is still lacking. This paper provides the results from a large 3-year project about the evaluation of sustainable treatment systems for removal of various micropollutants or disruptive effects at Swedish WWTPs and their environmental, economic and future sustainability. The presented results are based on our own pilot tests and related assessment and modelling efforts and provide a holistic view on advanced treatment of wastewater for removal of micropollutants.
Asunto(s)
Eliminación de Residuos Líquidos/métodos , Contaminantes Químicos del Agua/análisis , Preparaciones Farmacéuticas/análisis , Aguas del Alcantarillado , Desarrollo Sostenible , Aguas ResidualesRESUMEN
SETTING: Infectious Diseases Department, Karolinska University Hospital, Stockholm, Sweden. OBJECTIVE: To understand the challenges faced by nurses and physicians in the treatment of patients co-infected with the human immunodeficiency virus (HIV) and tuberculosis (TB), with special focus on opportunities for information and communication technology. DESIGN: Using a qualitative study design, on-site observations and informal discussions were carried out to become acquainted with the clinical context. Seven nurses and six physicians were purposefully selected to participate in one-to-one in-depth interviews inspired by cognitive task analysis. Interviews were audio recorded and transcribed verbatim, and analysed using inductive thematic analysis. RESULTS: Care providers faced challenges related to 1) the complexities inherent to TB-HIV co-treatment, 2) clinical knowledge and task standardisation, 3) care coordination and collaboration, 4) information management, and 5) engaging patients in their treatment. CONCLUSION: Support is needed on several levels to address the emerging burden of TB-HIV coinfection in Sweden. Educational material and tools need to be further developed to support care providers in making decisions about adequate care, and to support collaborative activities and communication among patients and care providers. Information and communication technology based solutions may provide an opportunity to address some of these challenges.
Asunto(s)
Comunicación , Infecciones por VIH/terapia , Conocimientos, Actitudes y Práctica en Salud , Tuberculosis/terapia , Conducta Cooperativa , Toma de Decisiones , Infecciones por VIH/complicaciones , Infecciones por VIH/epidemiología , Hospitales Universitarios , Humanos , Entrevistas como Asunto , Informática Médica , Relaciones Enfermero-Paciente , Enfermeras y Enfermeros/organización & administración , Relaciones Médico-Paciente , Médicos/organización & administración , Suecia/epidemiología , Tuberculosis/complicaciones , Tuberculosis/epidemiologíaRESUMEN
The occurrence of oral penicillin-resistant viridans group streptococci (VGS) was studied in 50 patients with either newly diagnosed acute leukaemia or autologous peripheral stem cell transplants. One patient was excluded because of Staphylococcus aureus growth in the stem cell harvest. VGS were isolated from the oral cavity of 48 of the remaining 49 patients. Of these 48 patients, 12 (25%) yielded VGS resistant (MIC > 2 mg/L) to penicillin. These 12 patients had a higher frequency of septicaemia (p 0.04) and more days of treatment with trimethoprim-sulphamethoxazole (p 0.04) than patients who harboured susceptible or intermediately resistant VGS (MIC 2 mg/L). There were no other statistically significant differences between the two groups. It is important to be aware of the high level of penicillin resistance in oral VGS in patients with haematological disease, and this parameter should be considered when selecting antibiotic therapy for cases of septicaemia caused by VGS in immunocompromised patients.
Asunto(s)
Leucemia Mieloide Aguda/microbiología , Mucosa Bucal/microbiología , Resistencia a las Penicilinas , Leucemia-Linfoma Linfoblástico de Células Precursoras/microbiología , Infecciones Estreptocócicas/microbiología , Estreptococos Viridans/efectos de los fármacos , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Femenino , Humanos , Huésped Inmunocomprometido , Leucemia Mieloide Aguda/tratamiento farmacológico , Leucemia Mieloide Aguda/terapia , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Estudios Prospectivos , Trasplante de Células Madre , Infecciones Estreptocócicas/complicaciones , Suecia , Combinación Trimetoprim y Sulfametoxazol/farmacología , Estreptococos Viridans/aislamiento & purificaciónRESUMEN
Three strains of a previously undescribed Actinomyces-like bacterium were isolated from human clinical specimens. Phenotypic studies indicated that the strains were members of the genus Actinomyces and were presumptively identified as Actinomyces turicensis. Comparative 16S rRNA gene sequencing studies showed that although the bacterium is phylogenetically closely related to Actinomyces turicensis, it nevertheless constitutes a new sub-line within the genus Actinomyces. Based on phenotypic and molecular chemical and molecular genetic evidence, it is proposed that the unknown Actinomyces-like bacterium from human clinical specimens be classified as Actinomyces funkei sp. nov. The type strain of Actinomyces funkei is CCUG 42773T (= CIP 106713T).
Asunto(s)
Actinomycetales/clasificación , Filogenia , Actinomycetales/genética , Actinomycetales/aislamiento & purificación , Adulto , Cefuroxima/uso terapéutico , ADN Bacteriano/genética , ADN Ribosómico/genética , Quimioterapia Combinada/uso terapéutico , Endocarditis Bacteriana/complicaciones , Endocarditis Bacteriana/tratamiento farmacológico , Femenino , Humanos , Datos de Secuencia Molecular , Fenotipo , ARN Bacteriano/genética , ARN Ribosómico 16S/genética , Infecciones Estafilocócicas/complicaciones , Infecciones Estafilocócicas/tratamiento farmacológico , Abuso de Sustancias por Vía Intravenosa/complicacionesRESUMEN
We describe the case of a young man with fever, chest pain and enteric symptoms. He developed myocarditis and Campylobacter was isolated in faeces.